In the United States, nearly 80 percent of clinical trials fail to meet their original enrollment … How Pharma Marketing Impacts Clinical Trial SuccessRead more
Pharma Marketing Analytics Dashboards: Data-Driven Strategy in a Regulated Industry
Pharmaceutical marketing sits at the intersection of complex science, fast-moving market dynamics, and stringent regulatory oversight. … Pharma Marketing Analytics Dashboards: Data-Driven Strategy in a Regulated IndustryRead more
Email Segmentation in Pharma Campaigns: Precision, Compliance, and the Next Frontier of Patient and HCP Engagement
Pharmaceutical marketers face a dual mandate: deliver clinically relevant information while meeting strict regulatory obligations. Email … Email Segmentation in Pharma Campaigns: Precision, Compliance, and the Next Frontier of Patient and HCP EngagementRead more
Pharmaceutical Partnership Marketing
Pharmaceutical companies increasingly rely on partnership marketing to expand market reach, accelerate innovation, and improve patient … Pharmaceutical Partnership MarketingRead more
Interactive Quizzes for Patient Awareness in Pharmaceutical Marketing
The Emergence of Interactive Patient Education in Pharma Marketing Pharmaceutical marketing stands at a critical transformation … Interactive Quizzes for Patient Awareness in Pharmaceutical MarketingRead more
Why Patient Recruitment Is the Biggest Problem in Clinical Trials Today
Patient recruitment remains the single most persistent bottleneck in clinical trials today. Despite advances in trial … Why Patient Recruitment Is the Biggest Problem in Clinical Trials TodayRead more
Common Clinical Trial Mistakes Pharma Companies Keep Repeating
Despite decades of regulatory guidance, expanded access to data, and repeated public postmortems of failed programs, … Common Clinical Trial Mistakes Pharma Companies Keep RepeatingRead more
How Misaligned R&D and Marketing Delay Drug Approvals in the U.S. Pharmaceutical Market
In the United States, drug approval timelines are becoming harder to predict. Despite record investment in … How Misaligned R&D and Marketing Delay Drug Approvals in the U.S. Pharmaceutical MarketRead more
Why Great Science Often Fails Commercially in Pharma
In the United States, bringing a new drug to market now costs more than $2 billion on average … Why Great Science Often Fails Commercially in PharmaRead more
Social Proof in Pharma Marketing: Evidence, Ethics, and Industry Impact
Pharmaceutical marketing has shifted rapidly from physician-centric promotion to a complex ecosystem that includes patients, caregivers, … Social Proof in Pharma Marketing: Evidence, Ethics, and Industry ImpactRead more